vs
美森（MATX）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是美森的1.8倍（$1.5B vs $851.9M），美森净利率更高（16.8% vs 12.9%，领先3.9%），Steris同比增速更快（9.2% vs -4.3%），Steris自由现金流更多（$199.5M vs $42.2M），过去两年Steris的营收复合增速更高（15.8% vs 8.6%）
美森公司（Matson, Inc.）是美国知名航运服务企业，总部位于夏威夷州火奴鲁鲁，成立于1882年。旗下子公司美森航运主营跨太平洋海运业务，服务覆盖夏威夷、阿拉斯加、关岛、密克罗尼西亚、太平洋诸岛、中国及日本等地区。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
MATX vs STE — 直观对比
营收规模更大
STE
是对方的1.8倍
$851.9M
营收增速更快
STE
高出13.5%
-4.3%
净利率更高
MATX
高出3.9%
12.9%
自由现金流更多
STE
多$157.3M
$42.2M
两年增速更快
STE
近两年复合增速
8.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $851.9M | $1.5B |
| 净利润 | $143.1M | $192.9M |
| 毛利率 | — | 43.8% |
| 营业利润率 | 16.9% | 18.3% |
| 净利率 | 16.8% | 12.9% |
| 营收同比 | -4.3% | 9.2% |
| 净利润同比 | 11.8% | 11.2% |
| 每股收益（稀释后） | $4.47 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MATXSTE
| Q4 25 | $851.9M | $1.5B | ||
| Q3 25 | $880.1M | $1.5B | ||
| Q2 25 | $830.5M | $1.4B | ||
| Q1 25 | $782.0M | $1.5B | ||
| Q4 24 | $890.3M | $1.4B | ||
| Q3 24 | $962.0M | $1.3B | ||
| Q2 24 | $847.4M | $1.3B | ||
| Q1 24 | $722.1M | $1.1B |
净利润MATXSTE
| Q4 25 | $143.1M | $192.9M | ||
| Q3 25 | $134.7M | $191.9M | ||
| Q2 25 | $94.7M | $177.4M | ||
| Q1 25 | $72.3M | $145.7M | ||
| Q4 24 | $128.0M | $173.5M | ||
| Q3 24 | $199.1M | $150.0M | ||
| Q2 24 | $113.2M | $145.4M | ||
| Q1 24 | $36.1M | $-1.4M |
毛利率MATXSTE
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 44.2% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | — | 43.6% | ||
| Q2 24 | — | 44.7% | ||
| Q1 24 | — | 40.2% |
营业利润率MATXSTE
| Q4 25 | 16.9% | 18.3% | ||
| Q3 25 | 18.3% | 18.2% | ||
| Q2 25 | 13.6% | 17.7% | ||
| Q1 25 | 10.5% | 14.6% | ||
| Q4 24 | 16.6% | 17.9% | ||
| Q3 24 | 25.2% | 16.5% | ||
| Q2 24 | 14.7% | 14.5% | ||
| Q1 24 | 5.1% | 22.0% |
净利率MATXSTE
| Q4 25 | 16.8% | 12.9% | ||
| Q3 25 | 15.3% | 13.1% | ||
| Q2 25 | 11.4% | 12.8% | ||
| Q1 25 | 9.2% | 9.8% | ||
| Q4 24 | 14.4% | 12.7% | ||
| Q3 24 | 20.7% | 11.3% | ||
| Q2 24 | 13.4% | 11.4% | ||
| Q1 24 | 5.0% | -0.1% |
每股收益（稀释后）MATXSTE
| Q4 25 | $4.47 | $1.96 | ||
| Q3 25 | $4.24 | $1.94 | ||
| Q2 25 | $2.92 | $1.79 | ||
| Q1 25 | $2.18 | $1.48 | ||
| Q4 24 | $3.69 | $1.75 | ||
| Q3 24 | $5.89 | $1.51 | ||
| Q2 24 | $3.31 | $1.46 | ||
| Q1 24 | $1.04 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.9M | $423.7M |
| 总债务越低越好 | $361.2M | $1.9B |
| 股东权益账面价值 | $2.8B | $7.2B |
| 总资产 | $4.6B | $10.6B |
| 负债/权益比越低杠杆越低 | 0.13× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资MATXSTE
| Q4 25 | $141.9M | $423.7M | ||
| Q3 25 | $92.7M | $319.2M | ||
| Q2 25 | $59.1M | $279.7M | ||
| Q1 25 | $122.0M | $171.7M | ||
| Q4 24 | $266.8M | $155.2M | ||
| Q3 24 | $270.3M | $172.2M | ||
| Q2 24 | $168.2M | $198.3M | ||
| Q1 24 | $25.9M | $207.0M |
总债务MATXSTE
| Q4 25 | $361.2M | $1.9B | ||
| Q3 25 | $370.9M | $1.9B | ||
| Q2 25 | $341.3M | $1.9B | ||
| Q1 25 | $351.1M | $1.9B | ||
| Q4 24 | $361.2M | $2.0B | ||
| Q3 24 | $370.9M | $2.2B | ||
| Q2 24 | $381.0M | $2.2B | ||
| Q1 24 | $390.8M | $3.1B |
股东权益MATXSTE
| Q4 25 | $2.8B | $7.2B | ||
| Q3 25 | $2.7B | $7.0B | ||
| Q2 25 | $2.6B | $7.0B | ||
| Q1 25 | $2.6B | $6.6B | ||
| Q4 24 | $2.7B | $6.4B | ||
| Q3 24 | $2.6B | $6.6B | ||
| Q2 24 | $2.4B | $6.4B | ||
| Q1 24 | $2.4B | $6.3B |
总资产MATXSTE
| Q4 25 | $4.6B | $10.6B | ||
| Q3 25 | $4.6B | $10.4B | ||
| Q2 25 | $4.5B | $10.4B | ||
| Q1 25 | $4.5B | $10.1B | ||
| Q4 24 | $4.6B | $10.0B | ||
| Q3 24 | $4.4B | $10.2B | ||
| Q2 24 | $4.3B | $10.1B | ||
| Q1 24 | $4.2B | $11.1B |
负债/权益比MATXSTE
| Q4 25 | 0.13× | 0.27× | ||
| Q3 25 | 0.14× | 0.27× | ||
| Q2 25 | 0.13× | 0.27× | ||
| Q1 25 | 0.13× | 0.29× | ||
| Q4 24 | 0.14× | 0.32× | ||
| Q3 24 | 0.15× | 0.33× | ||
| Q2 24 | 0.16× | 0.35× | ||
| Q1 24 | 0.16× | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $176.9M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $42.2M | $199.5M |
| 自由现金流率自由现金流/营收 | 5.0% | 13.3% |
| 资本支出强度资本支出/营收 | 15.8% | 6.6% |
| 现金转化率经营现金流/净利润 | 1.24× | 1.55× |
| 过去12个月自由现金流最近4个季度 | $153.7M | $917.1M |
8季度趋势，按日历期对齐
经营现金流MATXSTE
| Q4 25 | $176.9M | $298.2M | ||
| Q3 25 | $175.6M | $287.8M | ||
| Q2 25 | $105.6M | $420.0M | ||
| Q1 25 | $89.0M | $260.8M | ||
| Q4 24 | $174.7M | $332.8M | ||
| Q3 24 | $248.6M | $250.7M | ||
| Q2 24 | $307.9M | $303.7M | ||
| Q1 24 | $36.6M | $254.8M |
自由现金流MATXSTE
| Q4 25 | $42.2M | $199.5M | ||
| Q3 25 | $92.4M | $201.3M | ||
| Q2 25 | $19.3M | $326.4M | ||
| Q1 25 | $-200.0K | $189.9M | ||
| Q4 24 | $49.3M | $243.6M | ||
| Q3 24 | $189.0M | $148.8M | ||
| Q2 24 | $238.1M | $195.7M | ||
| Q1 24 | $-18.7M | $163.3M |
自由现金流率MATXSTE
| Q4 25 | 5.0% | 13.3% | ||
| Q3 25 | 10.5% | 13.8% | ||
| Q2 25 | 2.3% | 23.5% | ||
| Q1 25 | -0.0% | 12.8% | ||
| Q4 24 | 5.5% | 17.8% | ||
| Q3 24 | 19.6% | 11.2% | ||
| Q2 24 | 28.1% | 15.3% | ||
| Q1 24 | -2.6% | 14.6% |
资本支出强度MATXSTE
| Q4 25 | 15.8% | 6.6% | ||
| Q3 25 | 9.5% | 5.9% | ||
| Q2 25 | 10.4% | 6.7% | ||
| Q1 25 | 11.4% | 4.8% | ||
| Q4 24 | 14.1% | 6.5% | ||
| Q3 24 | 6.2% | 7.7% | ||
| Q2 24 | 8.2% | 8.4% | ||
| Q1 24 | 7.7% | 8.2% |
现金转化率MATXSTE
| Q4 25 | 1.24× | 1.55× | ||
| Q3 25 | 1.30× | 1.50× | ||
| Q2 25 | 1.12× | 2.37× | ||
| Q1 25 | 1.23× | 1.79× | ||
| Q4 24 | 1.36× | 1.92× | ||
| Q3 24 | 1.25× | 1.67× | ||
| Q2 24 | 2.72× | 2.09× | ||
| Q1 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MATX
| Ocean Transportation Segment | $704.2M | 83% |
| Logistics Services Segment | $147.7M | 17% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
